Ashvind A Prabahran (Ashvind Prabahran)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 7

Top Venues

Leukemia & lymphoma

European journal of haematology

Blood advances

Bone marrow transplantation

Peter MacCallum Cancer Centre

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Peter MacCallum Cancer Centre

Australia

Haematologist :: Clinical Haematology

Royal Melbourne Hospital

Australia

Haematologist :: Clinical Haematology

Publications

Ashvind A Prabahran, Jibran Durrani, Juan Coelho-Da Silva, Ruba Shalhoub, Jennifer Lotter, Olga Rios, David S Ritchie, Colin O Wu, Bhavisha A Patel, Neal S Young, Emma M Groarke
Safety and efficacy of immunosuppressive therapy for elderly patients with severe aplastic anaemia. British journal of haematology (2024)
Ashvind A Prabahran, Rachel M Koldej, Lynette Chee, Jeffrey Szer, David Ritchie
Non-relapse cytopenias following allogeneic stem cell transplantation, a case based review. Bone marrow transplantation 57 (10) (2022)
Ashvind A Prabahran, Rachel M Koldej, Lynette Chee, David S Ritchie
Clinical features, pathophysiology and therapy of Poor Graft Function Post Allogeneic Stem Cell Transplantation. Blood advances (2021)
Ashvind A Prabahran, Rachel Koldej, Lynette Chee, Eric Wong, David Ritchie
Evaluation of risk factors for and subsequent mortality from poor graft function (PGF) post allogeneic stem cell transplantation. Leukemia & lymphoma 62 (6) (2021)
Ashvind A Prabahran, David S Ritchie
Poor graft function, a significant and emerging clinical challenge post allogeneic stem cell transplantation. Leukemia & lymphoma 61 (12) (2020)
Ashvind A Prabahran, Surender K Juneja
Systemic mastocytosis with concurrent multiple myeloma. Blood 131 (13) (2019)
Ashvind A Prabahran, Mark Tacey, Shaun Fleming, Andrew Wei, Courtney Tate, Paula Marlton, Joel Wight, Andrew Grigg, Annabel Tuckfield, Jeff Szer, David Ritchie, Lynette Chee
Prognostic markers in core-binding factor AML and improved survival with multiple consolidation cycles of intermediate-/high-dose cytarabine. European journal of haematology (2018)

Ashvind A Prabahran.css-eqlu8i{font-size:small;padding-left:4px;} (Ashvind Prabahran)

Publication Activity (10 Years)

Top Topics

Top Venues

Ashvind A Prabahran (Ashvind Prabahran)